FFA
CLLS

Founders Financial Alliance’s Cellectis CLLS Stock Holding History

Founders Financial Alliance’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-100
Closed -$2K – 580
2020
Q3 		$2K Buy
+100
New +$1.77K ﹤0.01% 1187

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Founders Financial Alliance's CLLS Position: Q4 2020 in Review

Founders Financial Alliance sold out of Cellectis (CLLS) in Q4 2020, closing a stake of 100 shares — an estimated $2K sold.

Founders Financial Alliance first reported a position in CLLS in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 90 funds tracked by Wall St. Rank hold CLLS as of Q4 2020.

  • Founders Financial Alliance reported no remaining Cellectis position as of Q4 2020 after selling out during the quarter.
  • Founders Financial Alliance sold 100 Cellectis shares in Q4 2020, an estimated $2K.
  • Founders Financial Alliance first reported a position in Cellectis in Q3 2020 and held it in 1 quarter.
  • Founders Financial Alliance's Cellectis position peaked at $2K in Q3 2020.
  • 90 funds tracked by Wall St. Rank held Cellectis as of Q4 2020.

Based on Founders Financial Alliance's 13F filing for Q4 2020, filed 4 Feb 2021.